Skip to Content
Merck
  • Overfeeding During Lactation in Rats is Associated with Cardiovascular Insulin Resistance in the Short-Term.

Overfeeding During Lactation in Rats is Associated with Cardiovascular Insulin Resistance in the Short-Term.

Nutrients (2020-02-26)
Daniel González-Hedström, Lucía Guerra-Menéndez, Antonio Tejera-Muñoz, Sara Amor, María de la de la Fuente-Fernández, Beatriz Martín-Carro, Riansares Arriazu, Angel Luis Luis García-Villalón, Miriam Granado
ABSTRACT

Childhood obesity is associated with metabolic and cardiovascular comorbidities. The development of these alterations may have its origin in early life stages such as the lactation period through metabolic programming. Insulin resistance is a common complication in obese patients and may be responsible for the cardiovascular alterations associated with this condition. This study analyzed the development of cardiovascular insulin resistance in a rat model of childhood overweight induced by overfeeding during the lactation period. On birth day, litters were divided into twelve (L12) or three pups per mother (L3). Overfed rats showed a lower increase in myocardial contractility in response to insulin perfusion and a reduced insulin-induced vasodilation, suggesting a state of cardiovascular insulin resistance. Vascular insulin resistance was due to decreased activation of phosphoinositide 3-kinase (PI3K)/Akt pathway, whereas cardiac insulin resistance was associated with mitogen-activated protein kinase (MAPK) hyperactivity. Early overfeeding was also associated with a proinflammatory and pro-oxidant state; endothelial dysfunction; decreased release of nitrites and nitrates; and decreased gene expression of insulin receptor (IR), glucose transporter-4 (GLUT-4), and endothelial nitric oxide synthase (eNOS) in response to insulin. In conclusion, overweight induced by lactational overnutrition in rat pups is associated with cardiovascular insulin resistance that could be related to the cardiovascular alterations associated with this condition.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Vanadium(III) chloride, 97%
Sigma-Aldrich
Acetylcholine chloride, ≥99% (TLC)
Sigma-Aldrich
Charybdotoxin, ≥90% (HPLC)
Sigma-Aldrich
Anti-phospho eNOS Antibody (Ser1177), from rabbit, purified by affinity chromatography
Sigma-Aldrich
Anti-MAPK 1/2 Antibody, from rabbit
Sigma-Aldrich
Sodium nitrite, ACS reagent, ≥97.0%
Sigma-Aldrich
Nω-Nitro-L-arginine methyl ester hydrochloride, ≥97% (TLC), powder
Phenylephrine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Supelco
N-(1-Naphthyl)ethylenediamine dihydrochloride, GR for analysis ACS
Sigma-Aldrich
Anti-Akt1/PKBα Antibody, clone AW24 | 04-796, clone AW24, from rabbit